跳至主要内容
临床试验/NCT02129218
NCT02129218已完成不适用

A Pilot Study to Determine the Feasibility of a Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer

Case Comprehensive Cancer Center4 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2015年2月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
4
主要终点
Individual patient compliance, defined by following assigned target glycemic load index >= 75% of the time between weeks 4 and 12

研究概览

简要总结

This pilot clinical trial studies the feasibility of a low glycemic load diet in patients with stage I-III colon cancer. A low glycemic load diet includes foods that have low scores on the glycemic index. The glycemic index is a scale that measures how much a certain carbohydrate causes a person's blood sugar to rise. A low glycemic load diet may help decrease the chance of cancer coming back and improve the survival in patients with colon cancer.

详细描述

PRIMARY OBJECTIVES:

I. To determine the feasibility of following a low or medium glycemic load diet in patients with stage I-III (local-regional) colon cancer.

SECONDARY OBJECTIVES:

I. To determine patient-reported acceptability of diet. II. To determine nutritionist resources utilized. III. To evaluate the effect of lowering dietary glycemic load on body mass index (BMI), lipid metabolism and pro-oncogenic intermediaries of cellular metabolism.

OUTLINE: Patients are sequentially enrolled in 1 of 4 possible cohorts as needed based on the feasibility of the prior cohort.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must have stage I-III colon or rectal cancer and have undergone definitive therapy; definitive therapy may have included surgery alone, or surgery plus neoadjuvant and/or adjuvant therapy
  • Patients must regularly consume a diet with a glycemic load > 150 as estimated through the 3 day food recall
  • Patients must readily be available for a 3 month period and agree to participate in regular dietary adherence assessments (surveys and phone interviews)

排除标准

  • Current participation in an intervention targeting diet or exercise

研究组 & 干预措施

Cohort 1: Low glycemic load with standard diet

Experimental

Patients follow a low glycemic load diet with a standard dietary intervention for 12 weeks.

干预措施: questionnaire administration (Other)

Cohort 1: Low glycemic load with standard diet

Experimental

Patients follow a low glycemic load diet with a standard dietary intervention for 12 weeks.

干预措施: Standard Dietary Intervention (Behavioral)

Cohort 1: Low glycemic load with standard diet

Experimental

Patients follow a low glycemic load diet with a standard dietary intervention for 12 weeks.

干预措施: Low glycemic load (Behavioral)

Cohort 2: Low glycemic load with intensified diet

Experimental

Patients follow a low glycemic load diet with intensified dietary intervention for 12 weeks.

干预措施: questionnaire administration (Other)

Cohort 2: Low glycemic load with intensified diet

Experimental

Patients follow a low glycemic load diet with intensified dietary intervention for 12 weeks.

干预措施: laboratory biomarker analysis (Other)

Cohort 2: Low glycemic load with intensified diet

Experimental

Patients follow a low glycemic load diet with intensified dietary intervention for 12 weeks.

干预措施: Intensified Dietary Intervention (Behavioral)

Cohort 2: Low glycemic load with intensified diet

Experimental

Patients follow a low glycemic load diet with intensified dietary intervention for 12 weeks.

干预措施: Low glycemic load (Behavioral)

Cohort 3: Medium glycemic load with standard diet

Active Comparator

Patients follow a medium glycemic load diet with standard dietary intervention for 12 weeks.

干预措施: questionnaire administration (Other)

Cohort 3: Medium glycemic load with standard diet

Active Comparator

Patients follow a medium glycemic load diet with standard dietary intervention for 12 weeks.

干预措施: laboratory biomarker analysis (Other)

Cohort 3: Medium glycemic load with standard diet

Active Comparator

Patients follow a medium glycemic load diet with standard dietary intervention for 12 weeks.

干预措施: Standard Dietary Intervention (Behavioral)

Cohort 3: Medium glycemic load with standard diet

Active Comparator

Patients follow a medium glycemic load diet with standard dietary intervention for 12 weeks.

干预措施: Medium Glycemic Load (Behavioral)

Cohort 4: Medium glycemic load with intensified diet

Active Comparator

Patients follow a medium glycemic load diet with intensified dietary intervention for 12 weeks.

干预措施: questionnaire administration (Other)

Cohort 4: Medium glycemic load with intensified diet

Active Comparator

Patients follow a medium glycemic load diet with intensified dietary intervention for 12 weeks.

干预措施: laboratory biomarker analysis (Other)

Cohort 4: Medium glycemic load with intensified diet

Active Comparator

Patients follow a medium glycemic load diet with intensified dietary intervention for 12 weeks.

干预措施: Intensified Dietary Intervention (Behavioral)

Cohort 4: Medium glycemic load with intensified diet

Active Comparator

Patients follow a medium glycemic load diet with intensified dietary intervention for 12 weeks.

干预措施: Medium Glycemic Load (Behavioral)

结局指标

主要结局

Individual patient compliance, defined by following assigned target glycemic load index >= 75% of the time between weeks 4 and 12

时间窗: Up to week 12

This compliance rate will be determined through conducting a 24 hour telephone recall, every 2 weeks at random and calculating the glycemic load. For each dose cohort, the number and percentage of patients who are compliant will be summarized, with 90% confidence interval that accounts for the two-stage design.

次要结局

  • Hours of nutritionist time per week(Up to 12 weeks)
  • Food acceptability score(Up to 12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验